---
figid: PMC515345__zmk0090428070001
figtitle: Scheme of the sphingolipid metabolic pathway and sites of action of the
  distinct sphingolipid synthesis inhibitors
organisms:
- NA
pmcid: PMC515345
filename: zmk0090428070001.jpg
figlink: /pmc/articles/PMC515345/figure/fig1/
number: F1
caption: Scheme of the sphingolipid metabolic pathway and sites of action of the distinct
  sphingolipid synthesis inhibitors. FB1, LCS, and DMS inhibit the activity of dihydroceramide
  synthase, serine palmitoyl transferase, and sphingosine/sphinganine kinase, respectively.
papertitle: Polarized Membrane Traffic and Cell Polarity Development Is Dependent
  on Dihydroceramide Synthase-Regulated Sphinganine Turnover.
reftext: Sven C.D. van IJzendoorn, et al. Mol Biol Cell. 2004 Sep;15(9):4115-4124.
year: '2004'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.922938
figid_alias: PMC515345__F1
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC515345__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC515345__zmk0090428070001.html
  '@type': Dataset
  description: Scheme of the sphingolipid metabolic pathway and sites of action of
    the distinct sphingolipid synthesis inhibitors. FB1, LCS, and DMS inhibit the
    activity of dihydroceramide synthase, serine palmitoyl transferase, and sphingosine/sphinganine
    kinase, respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - myriocin
  - 3-ketosphinganine
  - Sphinganine
  - dihydroceramide
  - Ceramide
  - glycosphingolipids
  - phosphate
  - Serine
  - sphingomyelin
---
